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The purpose of the study was to compare the results of sepsis scoring (clinical examination and clinical pathology) to the
concentrations of matrix-metalloproteinases (MMPs) -2, -8, and -9; tissue-inhibitor of metalloproteinases (TIMPs) -1 and -2;
and inflammatory chemokines interleukin (IL) 1β and tumor-necrosis-factor-alpha (TNF-α) in plasma and peritoneal fluid of
equine colic patients. A modified sepsis scoring including general condition, heart and respiratory rate, rectal temperature,
mucous membranes, white blood cell count (WBC), and ionized calcium was applied in 47 horses presented with clinical signs
of colic. Using this scoring system, horses were classified as negative (n = 32, ≤6/19 points), questionable (n = 9, 7-9/19 points),
or positive (n = 6, ≥10/19 points) for sepsis. MMPs, TIMPs, IL-1β, and TNF-α concentrations were evaluated in plasma and
peritoneal fluid using species-specific sandwich ELISA kits. In a linear discriminant analysis, all parameters of sepsis scoring
apart from calcium separated well between sepsis severity groups (P < 0:05). MMP-9 was the only biomarker of high diagnostic
value, while all others remained insignificant. A significant influence of overall sepsis scoring on MMP-9 was found for
peritoneal fluid (P = 0:005) with a regression coefficient of 0.092, while no association was found for plasma (P = 0:085). Using a
MMP-9 concentration of >113 ng/ml in the peritoneal fluid was found to be the ideal cutoff to identify positive sepsis scoring
(≥10/19 points; sensitivity of 83.3% and specificity of 82.9%). In conclusion, MMP-9 was found to be a biomarker of high
diagnostic value for sepsis and endotoxemia in equine colic. The evaluation of peritoneal fluid seems preferable in comparison
to plasma. As abdominocentesis is commonly performed in the diagnostic work-up of equine colic, a pen-side assay would be
useful and easy-to-perform diagnostic support in the decision for therapeutic intervention.
1. Introduction
The equine gastrointestinal flora is rich in gram-negative
bacteria, which facilitate fermentation and digestive pro-
cesses [1]. In health, only slight amounts of endotoxin, i.e.,
cell-wall components of these bacteria, reach the circulation
due to the activity of specialized macrophages within the
hepatic sinusoids, the so called Kupffer cells. In strangulating
obstruction and severe gastrointestinal inflammation, for
example, colitis, large amounts of endotoxin accumulate
within the inflamed intestinal wall and reach the liver. When
the phagocytocic capacity of Kupffer cells is overwhelmed,
endotoxemia and possibly sepsis may develop [2].
In consequence, proteolytic enzymes are produced and
activated, in particular matrix metalloproteinases (MMPs).
The inflammatory response is mainly driven by the release
of cytokines from macrophages and monocytes at the site
of injury, followed by neutrophils releasing cytokines
themselves. These proinflammatory mediators especially
interleukin-1 (IL-1), tumor necrosis factor alpha (TNF-α),
and interleukin-6 (IL-6) stimulate the hepatic acute-phase
protein synthesis, once released into the circulation [3].
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LPS, TNF-α, interleukin-8, and granulocyte-colony-
stimulating factor (G-CSF) stimulate MMP production by
neutrophils in humans and other species [4]. Reactive oxygen
species from neutrophilic granules regulate the activity of
vascular MMPs, which are activated after contact with LPS
in men and horses [5–7], and it explains increased concentra-
tions in plasma. This is one of the key mechanisms of
hypotonia in sepsis in mice [8].
In health, a dynamic equilibrium between elastinolytic,
collagenolytic activity, and its inhibition is maintained for
physiological balance. This balance is controlled by proteo-
lytic degradation of extracellular matrix components by
MMPs and inhibition of MMP activity by specific tissue
inhibitors of matrix metalloproteinases (TIMPs) [9, 10].
Increased levels of different MMPs and TIMPs have been
shown in multiorgan disease with MMP-9 showing particu-
larly high diagnostic value. Gelatinolytic activity of MMP-2
and MMP-9 is increased in human patients suffering from
gram-negative sepsis [11]. Plasma concentrations of MMP-
9 increase up to 8 hours after LPS infusion in human subjects
and baboons [11, 12]. The same was evident in different
organs of mice after LPS infusion [5, 8, 13]. In horses, LPS
administration significantly increased MMP-2 and MMP-9
activities in plasma, which could be reduced by several non-
steroidal anti-inflammatory drugs (NSAIDs), in particular
pentoxifylline and oxytetracycline [14]. MMP-9 was also
shown to be a diagnostic indicator of survival during sepsis
[15]. An association of sepsis-related mortality disease with
TIMP-1/MMP-9 ratios was found in several studies for
adults and children [16–20]. Increased concentrations in
peritoneal fluid are likely to be produced by peritoneal macro-
phages in consequence of strangulating obstruction and
exudation of inflammatory mediators from the intestine as
shown in rats [5, 8, 13]. MMP-9, TIMP-1, and MMP-9/TIMP
ratio were good diagnostic or prognostic biomarkers of sepsis
after major abdominal surgery and were linked to sepsis-
associated organ dysfunction in rats and humans [21, 22]. This
was confirmed for other organ systems and sepsis-associated
diseases including acute kidney disease, acute respiratory fail-
ure, febrile neutropenia, and burn injuries [23–26]. TIMP-1
levels also correlated with sepsis-associated coagulopathy,
both with the degree of disseminated intravascular coagulation
(DIC) and disease severity [27].
In former studies, we could demonstrate significant
increases in MMP-2, MMP-8, and MMP-9 as well as
TIMP-1 and TIMP-2 concentrations in bronchoalveolar
lavage fluid of horses suffering from mild-to-moderate and
severe equine asthma, which normalized during successful
therapy [28, 29]. As MMP-8/TIMP ratios demonstrating col-
lagenolytic misbalance were of highest diagnostic value, we
were interested in the role of MMP-8 in extracelluar remod-
eling within the abdomen after colic surgery. In equine colic,
increased concentrations of another gelatinolytic MMP,
namely, MMP-2, were found in serum [30]. Other authors
found similar results of increased MMP-2 and MMP-9 levels
in equine arthritis and synovitis [31–33] as well as laminitis
[34–36]. The exact role of MMP-9 in acute phases of lamini-
tis remains uncertain though, as it appears to be present
largely in its inactive form [37]. ECM remodeling also plays
a role in ovulation and late gestation with MMP misbalance
possibly inhibiting pregnancy or leading to a high-risk
pregnancy or fetal membrane retention [38–40]. MMP-1
and possibly also MMP-2 and MMP-9 are overexpressed in
neoplastic tissue of equine sarcoids [41, 42] and corneal
ulceration [43, 44].
Abdominocentesis, followed by macroscopic, laboratory,
and cytological evaluation of peritoneal fluid, is commonly
performed in the work-up of equine colic and other gastroin-
testinal diseases. Quantifications of white and red blood cells,
protein, lactate, and glucose concentrations are helpful to
differentiate between strangulating and nonstrangulating dis-
orders, in particular of the small intestine [45]. Levels in
peritoneal fluid correlate with plasma concentrations, but
increase earlier and may be useful to predict the need for
surgery and estimate prognosis, especially using repeated
sampling over time. Blood and peritoneal fluid supernatant
TNF and IL-6 activities and endotoxin concentration were
significantly greater in horses with colic, compared with
healthy horses. In horses with colic, the peritoneal fluid endo-
toxin concentration and TNF and IL-6 activities were signif-
icantly greater than those in blood [46]. In addition, several
studies have been published focusing on the increases in
lactate dehydrogenase, creatine kinase, and alkaline phos-
phatase activity in comparison with lactate concentrations
[47–52]. Peritoneal fluid phosphate concentrations also had
reasonable sensitivity and specificity to predict intestinal
lesions requiring resection or euthanasia [53]. Another
promising marker for endotoxemia and equine colic might
also be procalcitonin in plasma and peritoneal fluid [54, 55].
In this study, we aimed to evaluate the diagnostic value of
several MMPs (MMP-2, MMP-9, MMP-8) and TIMPs
(TIMP-1 and TIMP-2) for equine colic, which is often asso-
ciated with endotoxemia and sepsis in case of strangulating
obstruction. In addition, important regulators of the hepatic
acute-phase protein synthesis (IL-1β and TNF-α) were eval-
uated, as strangulating obstruction may lead to fibrosis for-
mation in consequence of elastinolytic or collagenolytic
misbalance. A sepsis scoring system for the evaluation of
endotoxemia in equine colic patients has been published
[56]. Our hypothesis was that there is an association between
sepsis scoring, local and systemic MMP, TIMP, and cytokine
concentrations in equine colic. As prior studies found higher
concentrations of inflammatory markers in local samples
compared to plasma [46, 55, 57], we evaluated concentration
in peritoneal fluid in addition to plasma.
2. Materials and Methods
2.1. Sepsis Scoring. 47 horses presented to the Equine Clinic
of Freie Universitaet Berlin were included in the study. All
horses showed clinical signs of colic with various severities.
The sepsis scoring system published by Breuer and Schusser
[56] was modified to achieve the feasibility of sepsis scoring
in all hours of the day (emergency care). In this modified ver-
sion, it included general condition, heart and respiratory rate,
rectal temperature, mucous membranes, white blood cell
count (WBC), and ionized calcium counting up to 19 points
maximum (Table 1). Scoring results ≤ 6/19 points were
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classified as negative for sepsis, 7-9 points as questionable,
and ≥10/19 points as positive for sepsis.
2.2. Ethical Statement. All parameters included in the scoring
system were taken during the routine diagnostic workup of
colic in our clinic, and all MMP, TIMP, and chemokine con-
centrations in plasma and peritoneal fluid were evaluated
from samples taken during routine puncture of the jugular
vein and abdominocentesis for clinical pathology at admis-
sion or before surgery. Therefore, sampling of horses affected
by colic was not classified as animal experiments by the State
Office of Health and Social Affairs Berlin (LaGeSo). Owners’
consent to involve their horses in the study was obtained
during the admission process at the clinic.
2.3. Sample Taking Process. Blood samples were taken by
venipuncture of the jugular vein, and peritoneal fluid was
taken by abdominocentesis during the diagnostic workup
upon arrival at the clinic. While routine hematology was per-
formed using EDTA as a preservative, the remaining blood
was transferred to Na-citrate and heparin-containing tubes
to allow quantification of parameters studied. Plasma and
cell-free supernatant of peritoneal fluid were obtained after
centrifugation of the samples (10 minutes at 3500U/min in
Hettich Rotofix 32 centrifuge) and stored at -80°C until
assayed.
2.4. ELISA of MMP-2, MMP-8, MMP-9, TIMP-1, TIMP-2,
IL-1β, and TNF-α. The ELISAs used in this study were sand-
wich enzyme immunoassays for quantification of MMP,
TIMP, and chemokine concentrations. Standards and sam-
ples were set up in duplicates. The concentrations in plasma
and peritoneal fluid were determined using species-specific
ELISA kits (ELISA Kit for Equine Matrix Metalloproteinase
2 (MMP-2), Cloud Clone Corp., USA. ELISA Kit for Equine
Matrix Metalloproteinase 8 (MMP-8), Genorise Scientific
Inc., USA. Equine Matrix Metalloproteinase 9 (Gelatinase
B, 92 kDa Gelatinase, 92 kDa Type IV Collagenase)
(MMP9) FAST ELISA Kit, fzmb GmbH, Germany. ELISA
Kit for Equine Tissue Inhibitors of Metalloproteinase 1
(TIMP-1), Cloud Clone Corp., USA. ELISA Kit for Equine
Tissue Inhibitors of Metalloproteinase 2 (TIMP-2), Cloud
Clone Corp., USA. ELISA Kit for Equine Interleukin 1 beta
(IL-1ß), Cloud Clone Corp., USA. ELISA Kit for Equine
Tumor Necrosis Factor Alpha (TNF-α), Cloud Clone Corp.,
USA). An overview of the limits of detection and detection
ranges is given in Table 2. The absorbance was measured
with an ELISA microplate reader (ELISA microplate reader,
Tecan, Switzerland.) at 450nm immediately. Calculation of
the unknown sample concentration was made by an inverted
standard curve using the Excel software program.
2.5. Statistical Analysis. Data were statistically analyzed and
graphically presented using SPSS Statistics® (version 25).
The data were tested for normal distribution using the Sha-
piro Wilk test and visual inspection. To achieve normal dis-
tribution of data, MMP-9 and TIMP concentrations in
plasma and peritoneal fluid were logarithmized to the basis
of 10.
The influence of the overall sepsis score as well as single
parameters on MMP-2/-8/-9, TIMP-1/-2, and IL-1β/TNF-α
concentrations in plasma and peritoneal fluid, respectively,
was investigated using a general linear regression model
adjusted for confounding factors (age, breed, body weight,
and gender). A stepwise backward selection was used to elim-
inate variables that did not contribute significantly to the
model. The level of significance was set at P < 0:05. Multivar-
iable ANOVAmodels were also fitted to investigate the influ-
ence of the sepsis score, MMP, TIMP, and chemokine
concentrations on the total protein (TP), hematocrit
(HCT), lactate or fibrinogen (concerning plasma values),
and on TP and lactate (concerning peritoneal fluid values),
also adjusted for potential confounders age, breed, body
Table 1: Sepsis scoring modified from Breuer and Schusser [56]: classification in negative (≤6/19 points), questionable (7-9/19 points), or
positive (≥10/19 points) for sepsis.
Parameter 0 1 2 3
General condition Bright, alert Mildly reduced Moderately reduced Severely reduced
Heart rate/min 28-40 41-60 61-80 >80
Respiratory rate/min 10-14 15-25 26-45 >45
Temperature (°C) 37.5-38.0 37.0-37.4 or 38.1-38.5 36.5-36.9 or 38.6-39.0 <36.5 or >39.0
Mucous membranes Pinkish Mildly reddish Moderately reddish Highly reddish, toxic line
Ionized calcium (mmol/l) 1.5–1.8 <1.5
WBC (G/l) 4.9–12.6 4.0–4.8 or 12.7–15.0 3.0–3.9 or 15.1–20.0 <3.0 or >20.0
Table 2: Species, limits of detection, and detection ranges of ELISA
kits used for quantification of matrix-metalloproteinase (MMP),
tissue inhibitors of metalloproteinase (TIMP), interleukin (IL)-1β,
and tumor necrosis factor-alpha (TNF-α) concentration in equine
plasma and peritoneal fluid. Details on manufacturers are given in
the footnotes.
Parameter Species Limit of detection Detection range
MMP-2a Horse 0.56 ng/ml 1.56–100 ng/ml
MMP-8b Horse 18 pg/ml 93–6000 pg/ml
MMP-9c Horse 0.25 ng/ml 0.5–24 ng/ml
TIMP-1d Horse 0.241 ng/ml 0.625–40 ng/ml
TIMP-2e Horse 3.1 ng/ml 7.8–500 ng/ml
IL-1βf Horse 5.7 pg/ml 15.6–1000 pg/ml
TNF-αg Horse 2.9 pg/ml 7.8–500 pg/ml
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weight, and gender. A ROC analysis was performed to calcu-
late the cutoff values for MMP-9 concentrations with the
highest sensitivity and specificity concerning the detection
of overall sepsis scoring ≥ 10. The discriminatory power of
the single factors that contributed to the sepsis scoring was
investigated using linear discriminant analysis. With this
method, it can be evaluated which of the factors are well
suited to discriminate between the sepsis scoring groups.
The test of equality of group means was used to identify var-
iables that discriminate well between the groups (P value
<0.05). The assessment of the functions was done using the
eigenvalue, the percentage of variance that is due to the func-
tion, and the respective P values of Wilks’ lambda. The stan-
dardized canonical discriminant function coefficients were
used to calculate the mean discriminant coefficients explain-
ing the impact of the variables on the sepsis scoring groups.
3. Results
3.1. Sepsis Scoring. 47 horses of our hospital population pre-
senting with clinical signs of colic between March 2017 and
January 2018 participated in the study. These horses were
of various breeds (26 Warmbloods, 5 TB/SBs, 6 Western,
10 ponies), gender (26 mares, 14 geldings, 7 stallions), age
(14:3 ± 7:9 years), and weight (512 ± 135 kg). According to
the results of the sepsis scoring system, 32 horses were classi-
fied as negative (≤6/19 points), 9 as questionable (7-9/19
points), and 6 as positive (≥10/19 points) for sepsis. Horses
negative for sepsis had a mean overall sepsis score of 2:8 ±
1:8, the questionable group had a mean score of 7:6 ± 0:7,
and the positive group of 11:3 ± 2:0, respectively. An over-
view of the single parameters of sepsis scoring in the positive,
questionable, and negative sepsis group is given in Table 3.
All 6 horses with positive sepsis score went to surgery (4/6)
or were euthanized due to financial restraints (2/6). During
surgery, ischemic lesions were found in 4/4. Out of these,
3/4 survived until discharge; one was euthanized due to
severe postoperative ileus and a decision of the owner against
relaparotomy.
The discriminant analysis showed that all parameters of
sepsis scoring apart from ionized calcium (P = 0:403) dis-
criminated well between sepsis severity groups (P = 0:001
or lower). Wilks’ lambda recommended using two discrimi-
nant functions although the first function already accounted
for 90.6% of the total variance. Discoloration of mucous
membranes turned out to have the largest discriminatory
power (mean discriminant function 7.55), followed by leuko-
penia and general condition (mean discriminant function
4.86 and 2.49, resp.).
The color of mucous membranes had the largest impact
on the sepsis score. Including only the color of mucous mem-
branes leads to misclassification of only four horses, i.e.,
12.5%, compared to overall scoring. Other important vari-
ables were leukopenia and the general condition. The combi-
nation of these three variables classified all horses except one
correctly (3.1% misclassification) compared to overall scor-
ing. All six sepsis-positive horses were classified correctly.
Unfortunately, the number of sepsis positive horses was too
small to calculate reliable cutoff values for overall sepsis scor-
ing concerning the need for surgery, resection, or survival.
3.2. ELISA of MMP-2/-8/-9. MMP-2 concentrations in the
group negative for sepsis were 55.3 (42.3–72.1) ng/ml in
plasma and 7.8 (0.0–23.90) ng/ml in peritoneal fluid (PF),
respectively. In the questionable group, MMP-2 concentra-
tions were 47.0 (31.6–52.1) ng/ml in plasma and 11.4 (1.3–
24.0) ng/ml in PF. In sepsis-positive horses, concentrations
were 69.4 (54.7–84.4) ng/ml in plasma and 37.7 (0.0–90.4)
ng/ml in PF with no significant differences between sepsis
groups (P > 0:05).
Very low concentrations were measured for MMP-8: 0.80
(0.00–1.99) ng/ml in plasma and 0.00 (0.00–0.30) ng/ml in
PF in the group negative for sepsis, 1.60 (0.45–2.40) ng/ml
in plasma and 0.29 (0.00–0.75) ng/ml in PF in the question-
able group, and 1.79 (0.00–5.47) ng/ml in plasma and 0.05
(0.00–1.85) ng/ml in PF in horses tested positive for sepsis.
Again, no differences were found between sepsis groups
(P > 0:05).
In the group negative for sepsis, MMP-9 concentrations
were 107.8 (75.8–134.3) ng/ml in plasma and 51.9 (18.9–
74.8) ng/ml in PF, respectively. In the questionable group,
MMP-9 levels were 86.0 (67.5–105.4) ng/ml in plasma and
26.0 (7.5–182.1) ng/ml in peritoneal fluid. A significant
increase of both parameters was found in the group scoring
positive for sepsis with 143.8 (113.8–672.0) ng/ml in plasma
(P = 0:011) and 954.6 (119.4–8268.5) ng/ml in peritoneal
fluid (P = 0:002). An overview of the results of MMP concen-
trations in plasma and peritoneal fluid in the positive, ques-
tionable, and negative sepsis group is given in Table 4.
3.3. ELISA of TIMP-1/-2. TIMP-1 concentrations in the
group negative for sepsis were 472.4 (289.4–765.1) ng/ml in
plasma and 223.7 (180.4–272.9) ng/ml in PF, respectively.
In the questionable group, TIMP-1 concentrations were
723.5 (357.7–1295.2) ng/ml in plasma and 204.7 (188.1–
389.2) ng/ml in PF. In sepsis-positive horses, concentrations
were 907.2 (755.6–1114.3) ng/ml in plasma and 512.9
(448.2–1024.4) ng/ml in PF with no significant differences
between sepsis groups.
Table 3: Results of sepsis scoring in the groups negative (n = 32,
≤6/19 points), questionable (n = 8, 7-9/19 points), or positive
(n = 6, ≥10/19 points) for sepsis; median (lower quantile–upper
quantile). Significant differences in comparison with the sepsis
negative group are marked as ∗.
Parameter Negative Questionable Positive
General condition 0 (0–1) 2 (1–3) 3 (2–3)∗
Heart rate 1 (0–1) 1 (1–2) 2 (1–2)
Respiratory rate 1 (0–1) 2 (1–2) 1 (1–2)
Temperature 1 (0–1) 0 (0–1) 2 (2–3)
Mucous membranes 0 (0–0) 1 (1–1) 2 (2–3)∗
Ionized calcium 0 (0–0) 0 (0–0) 0 (0–1)
WBC 0 (0–0) 2 (0–3) 0 (0–3)
Overall score 3 (2–4) 8 (7–8) 10 (10–12)∗
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In the group negative for sepsis, TIMP-2 concentrations
were 86.5 (63.9–265.0) ng/ml in plasma and 0.0 (0.0–30.1)
ng/ml in peritoneal fluid, respectively. In the questionable
group, TIMP-2 levels were 98.3 (0.0–139.2) ng/ml in plasma
and 0.0 (0.0–0.0) in peritoneal fluid. In sepsis-positive horses,
concentrations were 133.7 (61.2–360.2) ng/ml in plasma and
25.2 (0.0–285.3) ng/ml in PF with no significant differences
between sepsis groups.
An overview of the results of TIMP concentrations in
plasma and peritoneal fluid in the positive, questionable,
and negative sepsis group is given in Table 5.
3.4. ELISA of IL-1β and TNF-α. Very low concentrations
were found for IL-1β and TNF-α. Concentrations of IL-1β
were 2.26 (2.20–2.50) pg/ml in plasma and 2.40 (2.23–2.68)
pg/ml in PF in the group negative for sepsis, 2.20 (1.60–
2.20) pg/ml in plasma and 2.45 (1.68–2.57) pg/ml in PF in
the questionable group, and 2.29 (2.20–2.34) pg/ml in plasma
and 2.59 (2.42–2.95) pg/ml in PF in horses tested positive for
sepsis. No differences were found between sepsis groups.
Concentrations of TNF-α were 7.9 (7.9–13.0) pg/ml in
plasma and 7.9 (7.9–8.1) pg/ml in PF in the group negative
for sepsis, 7.9 (6.7–7.9) pg/ml in plasma and 7.9 (6.7–10.5)
pg/ml in PF in the questionable group, and 8.9 (7.9–32.3)
pg/ml in plasma and 22.1 (7.9–34.2) pg/ml in PF in horses
tested positive for sepsis. Again, no differences were found
between the sepsis groups.
An overview of the results of IL-1β and TNF-α concen-
trations in plasma and peritoneal fluid in the positive, ques-
tionable, and negative sepsis group is given in Table 6.
3.5. Statistical Analysis. A significant influence of overall sep-
sis scoring on log MMP-9 was found for peritoneal fluid
(P = 0:005) with a regression coefficient of 0.092, while no
significant association was found for plasma (P = 0:085).
Log TIMP-1 in the peritoneal liquid was significantly influ-
enced by overall scoring (P = 0:018).
In blood, TIMP-1 was associated with HCT (regression
coefficient 9.447, P = 0:024). Lactate in blood was influenced
by MMP-9 (P = 0:012, regression coefficient 0.836). For TP,
no statistically significant factors could be identified.
ForMMP-2, MMP-8, TIMP-2, IL-1β, and TNF-α, no sig-
nificant differences were found between the sepsis groups,
and no correlations were found to the 8 parameters of overall
sepsis scoring classifying horses as septic (≥10/19 points) or
nonseptic (≤9/19 points) or the 3 subgroups (negative, ques-
tionable, positive). There was a positive association of MMP-
8 and lactate in plasma, one rising with the other, but this
trend remained insignificant (P = 0:088). There was also a
trend for IL-1β and lactate in PF (P = 0:053). A significant
positive association was found between IL-1β and TP in PF
(P = 0:023).
ROC analyses were used to find the optimal cutoff of
MMP-9 as well as TIMP-1 concentrations to identify animals
with positive sepsis scoring (≥10/19 points). A cutoff is
regarded as optimal when it has high sensitivity and high
specificity. This can be evaluated by calculating sensitivities
and specificities for a range of MMP-9 concentrations and
assess the results visually by a ROC graph. Regarding
MMP-9 concentrations in peritoneal fluid, 113 ng/ml turned
out to be optimal, since the sensitivity was 83.3% and the
specificity was 82.9%. For MMP-9 in plasma, the best con-
centration was 109 ng/ml with a sensitivity of 100%, but a
specificity of only 60%. For TIMP in peritoneal fluid, the
optimal cutoff value was 374ng/ml, which showed a sensitiv-
ity of 83.3% and a specificity of 91.4%. For TIMP values in
blood, 541ng/ml turned out to be the optimal cutoff value
with a sensitivity of 100% and a specificity of 57.1%.
4. Discussion
In this study, only MMP-9 was found to be a biomarker of
high diagnostic value for sepsis and endotoxemia in equine
colic. The evaluation of peritoneal fluid seems preferable in
comparison with plasma.
Apart from the overrepresentation of stallions, the study
population can be regarded as representative of our hospital
population of equine colic. The sepsis scoring was modified
from Breuer and Schusser [56] to increase its feasibility dur-
ing all hours of the day (emergency care). Blood cultures for
example are currently not a part of our routine diagnostic
workup of colic emergencies arriving at the clinic; therefore,
we decided to delete the parameter “infection” and reduced
the points leading to classification as negative, questionable,
or positive for sepsis accordingly. The results of the discrim-
inant analysis showed that all parameters apart from ionized
calcium contributed to the discrimination between sepsis
groups alone; therefore, we think that modification of the
score is defensible. The results of the discriminant analyses
showed that it would be possible to reduce the number of
Table 4: MMP-2, MMP-8, and MMP-9 concentrations in plasma and peritoneal fluid in the groups negative (n = 32, ≤6/19 points),
questionable (n = 8, 7-9/19 points), or positive (n = 6, ≥10/19 points) for sepsis; median (lower quantile–upper quantile). Significant
differences in comparison with the sepsis negative group are marked as ∗.
Parameter Negative Questionable Positive
MMP-2 (ng/ml) in plasma 55.3 (42.3–72.1) 47.0 (31.6–52.1) 69.4 (54.7–84.4)
MMP-2 (ng/ml) in peritoneal fluid 7.8 (0.0–23.90) 11.4 (1.3–24.0) 37.7 (0.0–90.4)
MMP-8 (ng/ml) in plasma 0.80 (0.00–1.99) 1.60 (0.45–2.40) 1.79 (0.00–5.47)
MMP-8 (ng/ml) in peritoneal fluid 0.00 (0.00–0.30) 0.29 (0.00–0.75) 0.05 (0.00–1.85)
MMP-9 (ng/ml) in plasma 107.8 (75.8–134.3) 86.0 (67.5–105.4) 143.8 (113.8–672.0)∗
MMP-9 (ng/ml) in peritoneal fluid 51.9 (18.9–74.8) 26.0 (7.5–182.1) 954.6 (119.4–8268.5)∗
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variables that account for the score even further. Inclusion of
only the color of mucous membranes, general condition, and
leukopenia would increase the risk of misclassification only
slightly. Nevertheless, we decided to go on with the overall
scoring to have the best statistical power when evaluating
the regression of MMP-9 concentrations in plasma or perito-
neal fluid and sepsis scoring.
Our hypothesis that there is a regression of local and sys-
temic MMP-9 concentrations and endotoxemia in equine
colic was confirmed. The regression coefficient for MMP-9
in plasma was weak though and the regression remained insig-
nificant, which is in unison with prior studies in other species
and organ systems, where higher concentrations were found
in local samples compared to plasma as well [28–33, 46–53].
Therefore, this was not unexpected and the reason why we
evaluated MMP-9 concentration in peritoneal plasma in addi-
tion to plasma. Apart from peritoneal macrophages, MMPs
are likely to be produced by neutrophils in septic or even non-
septic peritonitis in consequence of strangulating obstruction
and following the upregulation of inflammatorymediators like
TNF-α, interleukin-8, and G-CSF [4].
Interestingly, the mean MMP-9 concentration in the
group questionable for sepsis was lower than in the negative
group, which was visible in plasma and peritoneal fluid. This
may be simply caused by the much smaller number of horses
in the questionable versus the negative group; another expla-
nation may be that the synchronous activation of the elasti-
nolytic system may have reduced inflammatory mediators
favoring MMP production in the early phase of inflamma-
tion. At least in plasma, this is supported by TIMP level
increases in the questionable group, in particular TIMP-1.
During the calculation of optimal cutoff values for MMP-
9 concentration in plasma and peritoneal fluid, it became
obvious that these would be quite low in comparison with
mean values in horses scoring negative or questionable for
sepsis. The cutoff of 113 ng/ml in peritoneal fluid had reason-
able sensitivity and specificity in comparison with that of
plasma. As there was no regression between sepsis scoring
and MMP-9 concentrations in plasma, quantification of
MMP-9 in plasma cannot be recommended for clinical rou-
tine to aid the diagnosis of strangulating obstruction or to
help with the decision for surgery, antibiotics, or euthanasia.
On the other hand, a stable side or quick assay for MMP-9
evaluation from peritoneal fluid would be very interesting,
as abdominocentesis is commonly performed in horses pre-
senting with colic and unclear findings in clinical examina-
tion, transrectal palpation, or abdominal ultrasonography.
Other parameters from peritoneal fluid, i.e., lactate, are very
established in clinical routine regarding the decision for sur-
gery and the assumption of prognosis, but increases inMMP-
9 indicating gelatinolytic disbalance may be an early prog-
nostic indicator for fibrosis formation, which should be eval-
uated in longitudinal studies. As MMPs can be regarded as
markers associated with coagulation and fibrinolysis, they
could correlate with strangulating obstruction, need for sur-
gery, and survival in equine colic, where a misbalance of
coagulation and fibrinolysis was demonstrated in several
studies [58–61].
In humans, expression of MMP-9 during sepsis and
endotoxemia is known for a longer time [62]. LPS induces
transcription of the MMP-9 gene, and several groups have
investigated the levels of MMP-9 in relation to the severity
of sepsis in humans. Elevated levels of MMP-9 were observed
in critically ill patients [63], and a relation of MMP-9 levels to
the severity of sepsis was shown [3]. In a clinical study of
patients with septic shock, MMP-9 levels in nonsurvivors
were higher than those in survivors and healthy controls
[15]. The hub genes for MMP-9 were significantly related
to the prognosis of sepsis patients [64]. Latest studies in
human medicine suggest not only a coincidence but a pro-
moting role of MMPs in inflammation as shown in invasion
and migration of tumor cells [65].
The other parameters studied (MMP-2/-8, TIMP-1/-2,
IL-1β, and TNF-α) remained quite unrewarding, unfortu-
nately. Therefore, conclusions on an elastinolytic or collage-
nolytic misbalance cannot be realistically drawn at this
point of time. It was very difficult to find suitable ELISA kits
for equine samples. The manufacturers were asked for the
Table 5: TIMP-1 and TIMP-2 concentrations in plasma and peritoneal fluid in the groups negative (n = 32, ≤6/19 points), questionable (n = 8,
7-9/19 points), or positive (n = 6, ≥10/19 points) for sepsis; median (lower quantile–upper quantile). No significant differences.
Parameter Negative Questionable Positive
TIMP-1 (ng/ml) in plasma 472.4 (289.4–765.1) 723.5 (357.7–1295.2) 907.2 (755.6–1114.3)
TIMP-1 (ng/ml) in peritoneal fluid 223.7 (180.4–272.9) 204.7 (188.1–389.2) 512.9 (448.2–1024.4)
TIMP-2 (ng/ml) in plasma 86.5 (63.9–265.0) 98.3 (0.0–139.2) 133.7 (61.2–360.2)
TIMP-2 (ng/ml) in peritoneal fluid 0.0 (0.0–30.1) 0.0 (0.0–0.0) 25.2 (0.0–285.3)
Table 6: IL-1β and TNF-α concentrations in plasma and peritoneal fluid in the groups negative (n = 32, ≤6/19 points), questionable (n = 8, 7-
9/19 points), or positive (n = 6, ≥10/19 points) for sepsis. Median (lower quantile–upper quantile). No significant differences.
Parameter Negative Questionable Positive
IL-1β (pg/ml) in plasma 2.26 (2.20–2.50) 2.20 (1.60–2.20) 2.29 (2.20–2.34)
IL-1β (pg/ml) in peritoneal fluid 2.40 (2.23–2.68) 2.45 (1.68–2.57) 2.59 (2.42–2.95)
TNF-α (pg/ml) in plasma 7.9 (7.9–13.0) 7.9 (6.7-7.9) 8.9 (7.9–32.3)
TNF-α (pg/ml) in peritoneal fluid 7.9 (7.9–8.1) 7.9 (6.7–10.5) 22.1 (7.9–34.2)
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immunization antigens and validation data. The manufac-
turers explained the use of recombinant horse TIMP and
MMP as immunogenic and assured the minor validation
with horse samples. All ELISA kits were sold as validated
equine-specific tests as shown in Table 2. Nevertheless, all
tests apart from the MMP-9 kit had problems concerning
missing-specific native equine enzymes and proteins (mostly
recombinant proteins were used as immunization antigens
and ELISA standards). We relied on these tests after the man-
ufacturer’s recommendation. Furthermore, we did not find
major problems in prior studies using equine BALF and kits
from the same manufacturer and therefore did not include
zymography again. The possibility remains that the failure
to show any significant differences for the other assessments
besides MMP-9 may be a matter of sensitivity. Unfortu-
nately, due to the lack of fully validated assays, which are
accredited for a diagnostic approach in veterinary medicine,
we cannot see a loophole out of this dilemma at this point
of time. Worth mentioning apart from this, the samples were
taken at a very early time point prior to colic surgery. It is sur-
prising though that cytokines like IL-1β and TNF-α did not
show any differences correlating to the severity of clinical
signs or laboratory findings. It may be more informative to
study samples from the postoperative period to gain infor-
mation on extracellular remodeling within the abdominal
cavity favoring adhesion and fibrosis formation.
In conclusion, MMP-9 concentrations were increased in
plasma and peritoneal fluid of horses presenting with colic
and scoring positive for sepsis. Based on the results of this
primary project and so far only 6 horses classified as sepsis-
positive, MMP-9 may be useful to evaluate the severity of
endotoxemia and may have prognostic value for equine colic.
In further planned clinical studies, the overall specificity and
sensitivity of MMP-9 for sepsis diagnosis should be deter-
mined by receiver operating characteristic (ROC) for a bigger
number of horses with clearly defined sepsis (sepsis score
with proof of infection by blood culture or PCR) of further
origin than colic, in particular inflammatory gastrointestinal
disease. Here, we aim to investigate the role of MMP-9 for
(mortality-) prognosis or indication for surgery in case of
colic and also the possible use of MMP-9 for antibiotic stew-
ardship during postoperative care and the management of
complications like peritonitis or postoperative ileus.
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